Nurix Therapeutics, Inc.
NRIX · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $78 | $84 | $76 | $110 |
| Short-Term Investments | $350 | $402 | $474 | $500 |
| Receivables | $2 | $19 | $9 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $10 | $11 | $5 | $8 |
| Total Curr. Assets | $441 | $515 | $564 | $619 |
| Property Plant & Equip (Net) | $74 | $69 | $45 | $46 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $7 | $7 | $4 |
| Total NC Assets | $82 | $76 | $51 | $50 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $522 | $592 | $615 | $669 |
| Liabilities | – | – | – | – |
| Payables | $9 | $6 | $8 | $11 |
| Short-Term Debt | $4 | $5 | $7 | $8 |
| Tax Payable | $0 | $1 | $1 | $1 |
| Deferred Revenue | $26 | $27 | $31 | $38 |
| Other Curr. Liab. | $44 | $36 | $43 | $37 |
| Total Curr. Liab. | $82 | $76 | $90 | $96 |
| LT Debt | $53 | $47 | $20 | $20 |
| Deferred Rev, NC | $15 | $22 | $24 | $26 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $68 | $68 | $44 | $46 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $53 | $52 | $27 | $28 |
| Total Liabilities | $150 | $144 | $134 | $142 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$925 | -$839 | -$795 | -$739 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $1,297 | $1,286 | $1,276 | $1,266 |
| Total Equity | $372 | $448 | $481 | $527 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $522 | $592 | $615 | $669 |
| Net Debt | -$22 | -$32 | -$49 | -$82 |